يعرض 101 - 120 نتائج من 41,652 نتيجة بحث عن '(( significant ((largest decrease) OR (larger decrease)) ) OR ( significant potential group ))', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 101
  2. 102

    S1 File - حسب Jacob P. Rastas (20642173)

    منشور في 2025
    الموضوعات:
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107

    Scheme of g-λ model with larger values λ. حسب Zhanfeng Fan (20390992)

    منشور في 2024
    "…The findings suggest that when λ is respectively equal to 4.19, 8.57, 10, and 12.15, the peak particle velocity (PPV) of the transmitted waves is significantly close to the incident wave amplitude. Furthermore, when λ is fixed, the energy transmission coefficient increases with the incident wave amplitude but decreases with the incident wave frequency. …"
  8. 108
  9. 109
  10. 110

    Description of the ORICAMs cohort. حسب Julie Lopes (3857551)

    منشور في 2023
    الموضوعات:
  11. 111
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118

    Study Data. حسب Jonathan S. Jahr (2709088)

    منشور في 2025
    "…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"
  19. 119

    Study outcomes. حسب Jonathan S. Jahr (2709088)

    منشور في 2025
    "…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"
  20. 120

    Patient characteristics. حسب Jonathan S. Jahr (2709088)

    منشور في 2025
    "…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …"